Alicia Padilla-Galo

6PUBLICATIONS
27CO-AUTHORS
Rheumatology and arthritisMining, energy and natural resources lawOccupational epidemiologySocial epidemiologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Aug 19, 2026
Eosinophilic Inflammation in Severe Asthma: Pathophysiology, Clinical Identification, and Therapeutic Implications.

|Jun 26, 2026
Long-Term Adherence to Benralizumab and Sustained Clinical Benefits in Patients with Severe Eosinophilic Asthma: Insights from GALERNA, a Retrospective Real-World Study in Spain.

|Nov 27, 2025
ORBE II Study: Clinical Characteristics and Outcomes After Treatment with Benralizumab According to Airflow Obstruction Status and Smoking Habit.

Carlos Martínez-Rivera, Marina Blanco-Aparicio, Francisco Casas-Maldonado

|May 14, 2025
Early and Sustained Clinical Benefits of Benralizumab in Severe Eosinophilic Asthma: Findings from the ORBE II Study.

Pilar Ausín, María Eugenia Navarrete-Rouco, Luis Carazo

|May 28, 2021
Real-life cost-effectiveness of benralizumab in patients with severe asthma.

A Padilla-Galo, A J García-Ruiz, R Ch Levy Abitbol

|Jul 01, 2020
Real-life experience with benralizumab during 6 months.

A Padilla-Galo, RCh Levy-Abitbol, C Olveira

Pageof 1

Frequent Collaborators

3 joint publications

Jose Luis Sanchez-Trincado

2 joint publications

Marina Blanco-Aparicio

2 joint publications

Elisa Luzon

1 joint publications

María Eugenia Navarrete-Rouco